The frontier of women’s health care innovation - Ep. 102

Written exposure therapy can provide transformative, scalable PTSD care - Ep. 103

Episode about Written exposure therapy can provide transformative, scalable PTSD care Research completed for: Written exposure therapy can provide transformative, scalable PTSD care Key Findings: Written Exposure Therapy is a brief, five-session, structured writing intervention that repeatedly exposes individuals to the memory of their trauma on paper. In randomized controlled trials (RCTs), WET has shown PTSD symptom reductions comparable to gold-standard treatments such as Cognitive Processing Therapy (CPT) and Prolonged Exposure (PE), but with far fewer therapy hours, lower dropout rates, and minimal clinician training requirements—making it highly scalable for health systems that fac Verified Facts: 0 Unverified Claims: 1 Overall Confidence: 6.1/10 The research provides comprehensive coverage of the topic with 6 key facts, 1 helpful analogies, and addresses 4 common misconceptions.

The frontier of women’s health care innovation - Ep. 102

Episode about The frontier of women's health care innovation Research completed for: The frontier of women's health care innovation Key Findings: FemTech—technology-enabled products and services that focus on women’s biological and social health needs—has moved from niche period-tracking apps a decade ago to a diversified, evidence-backed sector spanning AI-powered diagnostics, wearables, tele-gynecology, and menopause care. Driven by long-standing research gaps, smartphone ubiquity, and rising investment, FemTech generated an estimated US$2.5 billion in venture funding in 2021 alone and is projected to reach a global market size of US$10 Verified Facts: 0 Unverified Claims: 0 Overall Confidence: 6.7/10 The research provides comprehensive coverage of the topic with 4 key facts, 1 helpful analogies, and addresses 4 common misconceptions.

Most Australians with dementia excluded from voluntary assisted dying, study finds - Ep. 101

Episode about Most Australians with dementia excluded from voluntary assisted dying, study finds Research completed for: Most Australians with dementia excluded from voluntary assisted dying, study finds Key Findings: A 2024 University of Southern Queensland study led by Prof. Kerstin Braun shows that 70–80 % of Australians who will develop dementia would not meet the legal criteria for voluntary assisted dying in any state or territory, primarily because every Australian VAD statute requires the person to have decision-making capacity both when they request and when they receive the life-ending medication. Dementia’s progressive cognitive decline means that, by the time symptoms are severe enough to satisfy Verified Facts: 1 Unverified Claims: 0 Overall Confidence: 6.6/10 The research provides comprehensive coverage of the topic with 5 key facts, 1 helpful analogies, and addresses 4 common misconceptions.

Popular joint supplement glucosamine linked to faster Alzheimer’s progression - Ep. 100

Episode about Popular joint supplement glucosamine linked to faster Alzheimer’s progression Research completed for: Popular joint supplement glucosamine linked to faster Alzheimer’s progression Key Findings: A large longitudinal cohort analysis involving older adults with mild cognitive impairment (MCI) reported that people who regularly took over-the-counter glucosamine were about 25 % more likely to convert to Alzheimer’s disease (AD) during the study period than non-users. Biomarker sub-studies showed higher levels of advanced glycation end-products and impaired insulin-signalling markers in cerebrospinal fluid among glucosamine users, suggesting a plausible biological pathway. The results do not Verified Facts: 0 Unverified Claims: 2 Overall Confidence: 6.1/10 The research provides comprehensive coverage of the topic with 5 key facts, 1 helpful analogies, and addresses 4 common misconceptions.

Alcohol and Health Risks — New Science on Daily Drinking

Alcohol and health risks: new science on daily drinking and mortality Fresh moderate drinking study challenges old rules on alcohol cancer risk and heart disease Understand how the science of alcohol consumption applies to your “one drink a day” habit—and what to do this week What You'll Learn: * Why new research shows that daily or “moderate” drinking isn’t automatically harmless—even if you stay under old guidelines * How the latest moderate drinking study from the Journal of Studies on Alcohol and Drugs links daily drinking and mortality, disability, and disease * What current science actually says about alcohol and heart disease versus cancer, and why the “protective” narrative is fading * A simple way to map out what a normal week of drinking really looks like for you (and why we often underestimate) * How to experiment with “one less drink” without feeling deprived or losing your social identity * Specific health effects of alcohol on sleep, mood, focus, and long-term brain and body health you can watch for in just one week * Practical strategies to lower the risks of daily alcohol use—even if you don’t want to quit completely * Questions to discuss with your doctor about alcohol and health risks, based on the newest science of alcohol consumption